Details for 2022165669
Up to date per 01.04.2026
Actions
Details for 2022165669
Granted/Registered
European Patent
28.09.2022 A
09.10.2024 B1
30.05.2017
US
201762512458 P
06.02.2018
US
201862626953 P
A61K 31/445 20060101AFI20220801BHEP
Owner
Amicus Therapeutics, Inc.3675 Market Street Philadelphia, PA 19104US
Representative
No representatives present
Inventor
CASTELLI, Jeff Philadelphia 19104US
Information about Fees